These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 6504502)
21. [Development of new cell fusion technique by laser device and application to bio-medical field]. Itagaki H; Doi H; Ohkohchi N; Satomi S Nihon Rinsho; 1997 Oct; 55(10):2780-7. PubMed ID: 9360406 [TBL] [Abstract][Full Text] [Related]
22. Cholesterol requirement of NS-1 mouse myeloma cells for growth in serum-free medium. Sato JD; Kawamoto T; McClure DB; Sato GH Mol Biol Med; 1984 Apr; 2(2):121-34. PubMed ID: 6533417 [TBL] [Abstract][Full Text] [Related]
23. Chemical typing of human kappa light chain subgroups expressed by human hybrid myelomas. Galfrè G; Milstein C Immunology; 1982 Jan; 45(1):125-8. PubMed ID: 6799391 [TBL] [Abstract][Full Text] [Related]
24. Production of stable heterohybridomas producing human monoclonal antibodies. Cooper MD; Kirkpatrick R Methods Mol Biol; 1995; 45():29-39. PubMed ID: 7550689 [No Abstract] [Full Text] [Related]
25. Murine monoclonal antibody development. Johnson DR Methods Mol Biol; 1995; 51():123-37. PubMed ID: 7581691 [No Abstract] [Full Text] [Related]
26. Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies. Zanella I; Verardi R; Negrini R; Osio L; Albertini A; Ghielmi S Year Immunol; 1993; 7():213-9. PubMed ID: 8396821 [No Abstract] [Full Text] [Related]
28. Production and characterization of monoclonal antibodies to bovine immunoglobulin G2. Srikumaran S; Guidry AJ; Goldsby RA Am J Vet Res; 1982 Jan; 43(1):21-5. PubMed ID: 7091814 [TBL] [Abstract][Full Text] [Related]
29. Early screening for hybrid antibodies. Loevborg U Dev Biol Stand; 1983; 55():173-9. PubMed ID: 6677530 [TBL] [Abstract][Full Text] [Related]
34. Enhancement of limiting dilution in cloning mouse myeloma-spleen hybridomas by human low density lipoproteins. Mao SJ; France DS J Immunol Methods; 1984 Dec; 75(2):309-16. PubMed ID: 6520402 [TBL] [Abstract][Full Text] [Related]
35. Dendritic cell vaccine therapy by immunization with fusion cells of interleukin-2 gene-transduced, spleen-derived dendritic cells and tumour cells. Ogawa F; Iinuma H; Okinaga K Scand J Immunol; 2004 May; 59(5):432-9. PubMed ID: 15140052 [TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines. Fuji H Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299 [TBL] [Abstract][Full Text] [Related]
37. Variants of an interspecies hybridoma with altered tumorigenicity and protective ability against mouse myeloma tumors. Baumal R; Musclow E; Farkas-Himsley H; Marks A Cancer Res; 1982 May; 42(5):1904-8. PubMed ID: 7066902 [TBL] [Abstract][Full Text] [Related]
38. Antitumor effect of immunization with fusion of dendritic cells and hepatocellular carcinoma cells in mice. Zhang H; Zheng SS; Jiang GP; Wu LH; Zhu F; Yang ZL Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):235-40. PubMed ID: 15138117 [TBL] [Abstract][Full Text] [Related]
39. Hybridomas as a source of antibodies. Scharff MD; Roberts S; Thammana P Hosp Pract (Off Ed); 1981 Jan; 16(1):61-6. PubMed ID: 6786973 [TBL] [Abstract][Full Text] [Related]
40. [Detection of HGPRT gene products before and after hybridization of reticulocytes with myeloma cells]. Xu Y; Tian JS; Liu YH; Zhang JB; Hu X; Huang AM; Xue SP Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Jun; 8(3):199-203. PubMed ID: 2946458 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]